Tipsheet
What matters at India’s listed companies
Earnings · Edible Oil · Micro cap

Vijay Solvex's revenue jumps 29% but profit stays flat

The edible oils processor grew topline sharply but couldn't convert it to profit growth. Margins are under pressure.


Mkt cap₹199 cr
P/E10.31×
ROE5.39%
Debt / eq.0.10
₹2,366 cr FY26 standalone revenue, up 29% from ₹1,831 cr a year earlier.

What's new

  • Standalone revenue grew ~29% to ₹2,366 cr in FY26 from ₹1,831 cr.
  • Net profit was nearly flat at ₹18.8 cr vs ₹18.4 cr, indicating margin compression.
  • Board also appointed a cost auditor, a routine procedural item.

Why this matters

A 29% revenue jump that delivers flat profit is the headline. For an edible oils processor, that usually means input costs or competitive pricing ate the growth. The numbers show volume or pricing strength on the top line but an inability to hold margins.

What we're watching

  • Margin recovery in coming quarters as input costs and pricing dynamics evolve.
  • Whether consolidated results reveal a different profitability picture than the standalone.
  • Management commentary on the drivers of the flat profit despite strong revenue growth.

The full read

Vijay Solvex grew revenue 29% to ₹2,366 crore in FY26. Profit stayed flat at ₹18.8 crore. That is the entire story. The edible oils processor found buyers but not margins. The gap between the ₹1,831 crore topline a year ago and today's figure is substantial. The gap between last year's ₹18.4 crore net profit and this year's ₹18.8 crore is not. For a commodity business, that pattern usually points to input cost inflation or pricing pressure that the top line alone can't fix. The board also made a routine cost auditor appointment. Nothing else suggests a change in trajectory.

Questions answered

How did Vijay Solvex's FY26 results perform?
The company reported standalone revenue of ₹2,366 crore, a 29% increase from ₹1,831 crore a year ago. However, net profit was essentially flat at ₹18.8 crore versus ₹18.4 crore.
What does the flat profit against rising revenue indicate?
It indicates margin compression. Despite a significant 29% jump in sales, the company could not translate the growth into higher profits, suggesting higher costs or lower profitability per unit sold.
Were there any other actions taken at the board meeting?
Besides approving the annual financial results, the board appointed a cost auditor for the company. This is a routine procedural item.
What was the key takeaway from the filing?
The key takeaway is the divergence between strong topline growth and stagnant profitability. The filing contains no new guidance, beats, or misses beyond the standard financial results.
Mentioned: Vijay Solvex Ltd. · FY26 standalone results · ₹2,366 cr revenue
Primary source BSE · NSE · Tijori

An independent reading of the company's own disclosure — the primary filing above is the final word.

Company snapshot

Vijay Solvex Ltd.

Edible Oils & Fats
₹219 cr
P/E 11.37×

Latest quarter · Mar 2026

Sales₹685 cr
Net profit₹7 cr
Op. margin+2.0%
EPS₹21.19

Strength & growth

Debt / equity0.10×
Current ratio4.04×
Sales CAGR+13.6%
EPS CAGR+3.9%